0001600132-18-000073.txt : 20180607 0001600132-18-000073.hdr.sgml : 20180607 20180607165434 ACCESSION NUMBER: 0001600132-18-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180605 FILED AS OF DATE: 20180607 DATE AS OF CHANGE: 20180607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT MATTHEW CENTRAL INDEX KEY: 0001267642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 18887076 MAIL ADDRESS: STREET 1: 227 WASHINGTON ST STREET 2: STE 200 CITY: CONSHONHOEKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_152840485873445.xml FORM 4 X0306 4 2018-06-05 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001267642 BENNETT MATTHEW C/O NEW MOUNTAIN CAPITAL, L.L.C. 787 SEVENTH AVENUE, 49TH FLOOR NEW YORK NY 10019 1 0 0 0 Stock Option (right to buy) 2.27 2018-06-05 4 A 0 38216 2.27 A 2019-06-05 2028-06-04 Common Stock 38216.0 38216 D Matthew Bennett 2018-06-05